NAV2024. 05. 30. Vált.-0,0100 Hozam típusa Investment Focus Alapkezelő
4,6700SGD -0,21% Újrabefektetés Részvény Sector Health / Pharma Invesco Management 

Befektetési stratégia

The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies. The Fund may use derivatives (complex instruments) to manage the Fund more efficiently, with the aim of reducing risk, reducing costs and/or generating additional capital or income. The Fund is actively managed and is not constrained by its benchmark, MSCI China A Onshore Health Care Index, which is used for comparison purposes. However, as the benchmark is a suitable proxy for the investment strategy, it is likely that some of the Fund"s holdings are also components of the benchmark. As an actively managed fund, this overlap will change and this statement may be updated from time to time.
 

Befektetési cél

The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies.
 

Törzsadatok

Hozam típusa: Újrabefektetés
Alapok Kategória: Részvény
Ország: Kína
Ágazat: Sector Health / Pharma
Benchmark: MSCI China A Onshore Health Care Index
Üzleti év kezdete: 02. 29.
Last Distribution: -
Letétkezelő bank: -
Származási hely: Luxemburg
Elosztás engedélyezése: Ausztria, Németország, Svájc
Alapkezelő menedzser: Chris Liu, Kehong Jiang
Alap forgalma: 486,11 mill.  EUR
Indítás dátuma: 2020. 12. 15.
Befektetési fókusz: -

Feltételek

Kibocsátási felár: 5,00%
Max. Administration Fee: 1,00%
Minimum befektetés: 1 200 000,00 SGD
Deposit fees: 0,01%
Visszaváltási díj: 0,00%
Egyszerűsített tájékoztató: Letöltés (Nyomtatási változat)
 

Alapkezelő

Alapkezelő cégek: Invesco Management
Cím: An der Welle 5, 60322, Frankfurt am Main
Ország: Németország
Internet: www.de.invesco.com
 

Eszközök

Részvények
 
96,91%
Készpénz
 
3,09%

Országok

Kína
 
65,14%
Készpénz
 
3,09%
Kajmán-szigetek
 
3,05%
Egyéb
 
28,72%

Ágazatok

Gyógyászat/Biotechnológia
 
50,29%
Gyógyászati termékek/eszközök
 
14,53%
Egészségügyi szolgáltatások
 
3,36%
Készpénz
 
3,09%
Egyéb
 
28,73%